Immuno-Biological Laboratories Co., Ltd. had a revenue of 211.48M in the quarter ending Jun 30, 2025, with -26.93%. This bring the company's revenue in the last twelve months to 951.89M, Increased -1.81%. In the fiscal year ending Dec 31, 2024, Immuno-Biological Laboratories Co., Ltd. had annual revenue of 969.53M with 18.71% growth.